Indium (111In) capromab pendetide (trade name Prostascint) is used to image the extent of prostate cancer.[1] Capromab is a mouse monoclonal antibody which recognizes a protein found on both prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA.[2] Pendetide acts as a chelating agent for the radionuclide indium-111. Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).[1]
Early trials with yttrium (90Y) capromab pendetide were also conducted.[3]
References
↑ 1.01.1"Indium-111 capromab pendetide in the management of recurrent prostate cancer". Expert Review of Anticancer Therapy8 (2): 175–81. February 2008. doi:10.1586/14737140.8.2.175. PMID 18279057.
↑WHO Drug Information
↑"A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy". Cancer Biotherapy & Radiopharmaceuticals14 (2): 99–111. April 1999. doi:10.1089/cbr.1999.14.99. PMID 10850293.
v
t
e
Diagnostic radiopharmaceuticals (ATC: V09)
Central nervous system
99mTc (Exametazime)
123I (Ioflupane
Iofetamine
Iomazenil)
18F (Florbetapir, Flutemetamol)
Skeletal system
99mTc (Medronic acid)
Renal
123I (Sodium iodohippurate)
64Cu (Cu-ETS2)
Gastrointestinal/Hepatic
75Se (SeHCAT)
Respiratory system
133Xe
81mKr
99mTc (99mTc-MAA)
Cardiovascular system
99mTc (Sestamibi
Tetrofosmin)
111In (Imciromab)
82Rb (Rubidium chloride)
Inflammation/infection
99mTc (Exametazime
Sulesomab
Tilmanocept)
111In
67Ga
Tumor
99mTc (Arcitumomab
Votumumab
Hynic-octreotide)
111In (Capromab pendetide
Satumomab pendetide)
125I (Minretumomab)
123I / 131I (Iobenguane)
18F (Fluciclovine
Fludeoxyglucose
Fluoroethyltyrosine
Sodium fluoride)
Adrenal cortex
123I
125I / 131I (Iodocholesterol)
Radionuclides (including tracers)
positron (PET list)
11C ([11C]ME@HAPTHI
25B-NBOMe (Cimbi-36)
Acetate
Choline
Carfentanil
DASB
DTBZ
Flumazenil
Methionine
N-Methylspiperone
Pittsburgh compound B
Raclopride
Verapamil)
13N (Ammonia)
15O (Water)
18F (Altanserin
Desmethoxyfallypride
FMISO
Fallypride
Florbetaben
Florbetapir
Flubatine
Fluciclovine
Fludeoxyglucose (18F) (FDG)-glucose analogue
Flumazenil
Fluorocholine
Fluorodeoxysorbitol (FDS)
Fluorodopa
Fluorothymidine F-18
Fluspidine
Flutemetamol
MPPF
Mefway
Nifene
N-Methylspiperone
FET
Setoperone)
64Cu
68Ga
82Rb (Rubidium chloride)
gamma ray/photon (SPECT/scintigraphy)
51Cr
57Co
67Ga
75Se
81mKr
99mTc
111In
123I
125I
131I
133Xe
153Sm
201Tl
v
t
e
Monoclonal antibodies for tumors
Tumor ("-t(u[m])-")
Human ("-tumu-")
Adecatumumab§
Ascrinvacumab§
Cixutumumab§
Conatumumab§
Daratumumab
Drozitumab§
Duligotumab§
Dusigitumab§
Enfortumab vedotin†
Enoticumab§
Figitumumab§
Ganitumab†
Glembatumumab vedotin†
Intetumumab§
Ipilimumab
Iratumumab§
Istiratumab
Icrucumab§
Lexatumumab§
Lucatumumab§
Mapatumumab§
Narnatumab§
Necitumumab
Nesvacumab§
Nivolumab
Ofatumumab
Olaratumab†
Panitumumab
Patritumab§
Pembrolizumab
Pritumumab§
Radretumab§
Ramucirumab
Rilotumumab†
Robatumumab§
Seribantumab§
Tarextumab§
Teprotumumab†
Tovetumab§
Vantictumab§
Votumumab§
Zalutumumab†
"-melu-" (melanoma)
Flanvotumab§
Mouse ("-tumo-")
Altumomab pentetate
Anatumomab mafenatox
Arcitumomab
Bectumomab
Blinatumomab
Detumomab
Ibritumomab tiuxetan
Lilotomab
Minretumomab
Mitumomab
Moxetumomab pasudotox†
Naptumomab estafenatox
Nofetumomab merpentan
Pemtumomab†
Pintumomab
Racotumomab
Satumomab pendetide
Solitomab
Taplitumomab paptox
Tenatumomab
Tositumomab
3F8
"-govo-" (ovarian tumor)
Abagovomab
Igovomab
Oregovomab
"-pro-" (prostate tumor)
Capromab pendetide
"-colo-" (colonic tumor)
Edrecolomab
Nacolomab tafenatox
Chimeric ("-tuxi-")
Amatuximab§
Bavituximab§
Brentuximab vedotin
Carotuximab†
Cetuximab
Derlotuximab biotin§
Dinutuximab
Ensituximab§
Futuximab§
Girentuximab†
Indatuximab ravtansine§
Isatuximab†
Loncastuximab tesirine
Margetuximab†
Rituximab#
Siltuximab
Ublituximab†
IMAB362
"-mexi-" (melanoma): Ecromeximab§
Humanized ("-tuzu-")
Abituzumab§
Alemtuzumab
Bevacizumab
Bivatuzumab mertansine§
Brontictuzumab§
Cantuzumab mertansine§
Cantuzumab ravtansine§
Cirmtuzumab
Citatuzumab bogatox§
Clivatuzumab tetraxetan
Cofetuzumab pelidotin
Dacetuzumab§
Demcizumab§
Dalotuzumab§
Denintuzumab mafodotin§
Elotuzumab
Emactuzumab§
Emibetuzumab§
Enoblituzumab§
Etaracizumab§
Farletuzumab§
Ficlatuzumab§
Flotetuzumab§
Gemtuzumab ozogamicin‡
Imgatuzumab§
Inotuzumab ozogamicin†
Labetuzumab§
Lifastuzumab vedotin§
Lintuzumab§
Lorvotuzumab mertansine§
Lumretuzumab§
Matuzumab§
Milatuzumab§
Nimotuzumab†
Obinutuzumab
Ocaratuzumab§
Otlertuzumab§
Onartuzumab§
Oportuzumab monatox†
Parsatuzumab§
Pertuzumab
Pinatuzumab vedotin§
Polatuzumab vedotin†
Rosmantuzumab
Rovalpituzumab tesirine†
Sacituzumab govitecan†
Sibrotuzumab§
Simtuzumab§
Tacatuzumab tetraxetan§
Tigatuzumab§
Trastuzumab
Tucotuzumab celmoleukin§
Vandortuzumab vedotin§
Vanucizumab§
Veltuzumab§
Vorsetuzumab mafodotin§
CBR96-doxorubicin immunoconjugate
PankoMab
"-gozu-" (ovarian tumor)
Sofituzumab vedotin§
Rat/mouse hybrid ("-tumaxo-")
Catumaxomab
Ertumaxomab§
Chimeric + humanized ("-tuxizu-")
Depatuxizumab mafodotin†
Duvortuxizumab
Ontuxizumab§
#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III
0.00
(0 votes)
Original source: https://en.wikipedia.org/wiki/Indium (111In) capromab pendetide. Read more